SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-03-000447
Filing Date
2003-02-14
Accepted
2003-02-14 14:00:27
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 NEUROCRINE BIOSCIENCES SCHEDULE 13G w83576asc13gza.htm SC 13G/A 21803
  Complete submission text file 0000950133-03-000447.txt   23902
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 8586587600
NEUROCRINE BIOSCIENCES INC (Subject) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46089 | Film No.: 03565943
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000